Open AccessAbstract CT287: CANOPY-A: A phase III, multicenter, randomized trial evaluating canakinumab versus placebo as adjuvant therapy in patients with completely resected non-small cell lung cancer (NSCLC)
Author(s) -
Edward B. Garon,
Andrea Ardizzoni,
Fabrice Barlési,
Byoung Chul Cho,
Pedro De Marchi,
Yasushi Goto,
Dariusz M. Kowalski,
Shun Lü,
Luis PazAres,
David R. Spigel,
Alexander I. Spira,
Michael Thomas,
Mimi Leung,
Jason Baum,
Zewen Zhu,
Bijoyesh Mookerjee,
James ChihHsin Yang
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct287
Subject(s) - medicine , canakinumab , placebo , oncology , radiation therapy , non small cell lung cancer (nsclc) , cancer , lung cancer , surgery , disease , pathology , alternative medicine , anakinra , a549 cell